Naprosyn and Plendil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naprosyn (naproxen) and Plendil (felodipine). Common drug interactions include constipation among females and injury among males.

The phase IV clinical study analyzes what interactions people have when they take Naprosyn and Plendil. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.



On Jul, 15, 2026

36 people who take Naprosyn and Plendil together, and have interactions are studied.

Naprosyn and Plendil drug interactions.

What are the common drug interactions of Naprosyn and Plendil, by gender? *:

female:

  1. Constipation
  2. Dyspepsia (indigestion)
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Hypoxia (low oxygen in tissues)
  6. Interstitial lung disease
  7. Lacrimation increased
  8. Nasal obstruction (blockage of nose)
  9. Nasal turbinate hypertrophy (nasal turbinates become enlarged)
  10. Oedema (fluid collection in tissue)

male:

  1. Injury
  2. Abscess (pus)
  3. Decreased interest
  4. Dyslipidaemia (abnormal amount of lipids)
  5. Dyspnoea (difficult or laboured respiration)
  6. Ejection fraction decreased (systolic heart failure)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Herpes zoster
  9. Hyperplasia (enlargement of an organ or tissue)
  10. Interstitial lung disease

What are the common drug interactions of Naprosyn and Plendil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Atrophy (wasting away of a part of the body)
  4. Bladder cancer
  5. Bladder mass
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Cardiac arrest
  10. Cardiac failure congestive

30-39:

  1. Cystitis interstitial (unknown cause characterized by bladder pain)
  2. Kidney infection
  3. Stomach discomfort (pain in abdomen)

40-49:

  1. Depression
  2. Tablet in stool

50-59:

  1. Asthma
  2. Blood creatinine increased
  3. Chest discomfort
  4. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  5. Constipation
  6. Dyspepsia (indigestion)
  7. Dyspnoea (difficult or laboured respiration)
  8. Dyspnoea exertional (breathlessness or shortness of breath)
  9. Hypoxia (low oxygen in tissues)
  10. Interstitial lung disease

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Arterial embolism (sudden interruption of blood flow to an organ or body part due to an embolus adhering to the wall of an artery blocking the flow of blood)
  3. Peripheral ischaemia (impaired circulation to an extremity)
  4. Pulse absent
  5. Renal impairment (severely reduced kidney function)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Hypotension (abnormally low blood pressure)
  8. Lung disorder (lung disease)
  9. Pain in limb
  10. Productive cough

What are the existing conditions these people have? *

  1. Bone Disorder: 18 people, 50.00%
  2. Multiple Myeloma (cancer of the plasma cells): 10 people, 27.78%
  3. Asthma: 3 people, 8.33%
  4. Dyspnea (difficult or laboured breathing): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and Plendil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naprosyn and Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plendil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and felodipine (the active ingredients of Naprosyn and Plendil, respectively), and Naprosyn and Plendil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: